News Focus
News Focus
Followers 0
Posts 188
Boards Moderated 0
Alias Born 08/19/2011

Re: BoomandGloom post# 343924

Thursday, 10/27/2011 2:46:45 PM

Thursday, October 27, 2011 2:46:45 PM

Post# of 435790
The Barclays analyst's move has very little influence on the sale of the company.

Remember, the added value of the company over its value as a stand alone company derives from the ability of a large company to use IDCC's IP as a weapon in the patent wars. That value is not questioned by the Barclays analyst report. His report is his opinion of the value of IDCC if it were to stay independent, and he makes some big mistakes in not accounting for the reduced licensing that may be happening because of the sale process, and not accounting at all for the value of the patents in a potential future sale. These points were made by the Morgan Keegan analyst that JimLur quoted an email of to the Barclays analyst ( http://investorshub.advfn.com/boards/read_msg.aspx?message_id=68408260 )

I agree with others that investors are making too much of this target price reduction from Barclays. This too shall pass, and investors in IDCC will be rewarded.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IDCC News